192 related articles for article (PubMed ID: 28208175)
21. Association Between Adrenal-Restrictive HSD3B1 Inheritance and Hormone-Independent Subtypes of Endometrial and Breast Cancer.
McManus JM; Vargas R; Bazeley PS; Schumacher FR; Sharifi N
JNCI Cancer Spectr; 2022 Sep; 6(5):. PubMed ID: 35947687
[TBL] [Abstract][Full Text] [Related]
22. Expression and gene variation studies deny association of human HSD3B1 gene with aldosterone production or blood pressure.
Verwoert GC; Hofland J; Amin N; Mattace-Raso FU; Sijbrands EJ; Hofman A; van den Meiracker AH; Uitterlinden AG; van Duijn CM; de Jong FH; Danser AH
Am J Hypertens; 2015 Jan; 28(1):113-20. PubMed ID: 24951726
[TBL] [Abstract][Full Text] [Related]
23. Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer.
Flanagan MR; Doody DR; Voutsinas J; Wu Q; Banda K; Sharifi N; Li CI; Gadi VK
Ann Surg Oncol; 2022 Oct; 29(11):7194-7201. PubMed ID: 35776258
[TBL] [Abstract][Full Text] [Related]
24. Association of HSD17B3 and HSD3B1 polymorphisms with acne vulgaris in Southwestern Han Chinese.
Yang XY; Wu WJ; Yang C; Yang T; He JD; Yang Z; He L
Dermatology; 2013; 227(3):202-8. PubMed ID: 24157973
[TBL] [Abstract][Full Text] [Related]
25. HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome.
Tu YA; Lin SJ; Chen PL; Chou CH; Huang CC; Ho HN; Chen MJ
J Formos Med Assoc; 2019 Aug; 118(8):1225-1231. PubMed ID: 31056381
[TBL] [Abstract][Full Text] [Related]
26. Importance of 3β-hydroxysteroid dehydrogenases and their clinical use in prostate cancer.
Shiota M; Endo S; Tsukahara S; Tanegashima T; Kobayashi S; Matsumoto T; Eto M
Endocr Relat Cancer; 2024 Jul; 31(7):. PubMed ID: 38688318
[TBL] [Abstract][Full Text] [Related]
27. Codon 367 polymorphism of the human type I 3 beta-hydroxysteroid dehydrogenase/isomerase gene (HS5DB3).
Rhéaume E; Sirois I; Labrie F; Simard J
Nucleic Acids Res; 1991 Nov; 19(21):6060. PubMed ID: 1945895
[No Abstract] [Full Text] [Related]
28. Estrogen synthesis genes CYP19A1, HSD3B1, and HSD3B2 in hypertensive disorders of pregnancy.
Shimodaira M; Nakayama T; Sato I; Sato N; Izawa N; Mizutani Y; Furuya K; Yamamoto T
Endocrine; 2012 Dec; 42(3):700-7. PubMed ID: 22638611
[TBL] [Abstract][Full Text] [Related]
29. Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells.
Lachance Y; Luu-The V; Labrie C; Simard J; Dumont M; de Launoit Y; Guérin S; Leblanc G; Labrie F
J Biol Chem; 1992 Feb; 267(5):3551. PubMed ID: 1737804
[No Abstract] [Full Text] [Related]
30. Genetic variation in the HSD3B1 gene and recurrent spontaneous abortions.
Ntostis P; Peraki O; Boulgari A; Agiannitopoulos K; Pantos K; Lamnissou K
J Matern Fetal Neonatal Med; 2012 Apr; 25(4):408-10. PubMed ID: 21631238
[TBL] [Abstract][Full Text] [Related]
31. Gene Polymorphism-related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer.
Fujimoto N; Shiota M; Tomisaki I; Minato A
Clin Genitourin Cancer; 2017 Jun; 15(3):337-342. PubMed ID: 28188049
[TBL] [Abstract][Full Text] [Related]
32. Proximal GATA-binding sites are essential for human HSD3B1 gene transcription in the placenta.
Lai TC; Li HF; Li YS; Hung PY; Shyu MK; Hu MC
Sci Rep; 2017 Jun; 7(1):4271. PubMed ID: 28655875
[TBL] [Abstract][Full Text] [Related]
33. Cessation of long-term adjuvant androgen deprivation therapy after radical prostatectomy: is it feasible?
Taguchi S; Fukuhara H; Morikawa T; Matsumoto A; Miyazaki H; Nakagawa T; Fujimura T; Kume H; Igawa Y; Homma Y
Jpn J Clin Oncol; 2016 Dec; 46(12):1143-1147. PubMed ID: 27620729
[TBL] [Abstract][Full Text] [Related]
34. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
[TBL] [Abstract][Full Text] [Related]
35. The HIF1A functional genetic polymorphism at locus +1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castration.
Fraga A; Ribeiro R; Príncipe P; Lobato C; Pina F; Maurício J; Monteiro C; Sousa H; Calais da Silva F; Lopes C; Medeiros R
Eur J Cancer; 2014 Jan; 50(2):359-65. PubMed ID: 24090974
[TBL] [Abstract][Full Text] [Related]
36. Gene expression of androgen metabolising enzymes in benign prostatic hyperplasia.
Otpuschennikov AA; Khvostova EP; Krasilnikov CE; Gulyaeva LF
Klin Lab Diagn; 2013 Oct; (10):52-4, 16-8. PubMed ID: 24640095
[TBL] [Abstract][Full Text] [Related]
37. Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT.
Handy WF; Schmidt KT; Price DK; Figg WD
Cancer Biol Ther; 2020 Sep; 21(9):782-784. PubMed ID: 32791030
[TBL] [Abstract][Full Text] [Related]
38. Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting Summary.
Hofmann MR; Hussain M; Dehm SM; Beltran H; Wyatt AW; Halabi S; Sweeney C; Scher HI; Ryan CJ; Feng FY; Attard G; Klein E; Miyahira AK; Soule HR; Sharifi N
Urology; 2021 Sep; 155():165-171. PubMed ID: 33373705
[TBL] [Abstract][Full Text] [Related]
39. Genetic linkage mapping of HSD3B1 and HSD3B2 encoding human types I and II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase close to D1S514 and the centromeric D1Z5 locus.
Morissette J; Rhéaume E; Leblanc JF; Luu-The V; Labrie F; Simard J
Cytogenet Cell Genet; 1995; 69(1-2):59-62. PubMed ID: 7835088
[TBL] [Abstract][Full Text] [Related]
40. [Circadian clocks and hypertension].
Doi M; Okamura H
Nihon Yakurigaku Zasshi; 2012 May; 139(5):227-8. PubMed ID: 22696790
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
